Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00631670 · ClinicalTrials.gov registry record · NA

Stereotactic Body Radiation Therapy (SBRT) for Tumors Near the Spinal Cord

A NA study, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
21
Enrollment target

NCT00631670 is a NA study that has completed, run by University of Florida. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00631670, a NA study, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

The purpose of this research study is to determine if Stereotactic Body Radiation Therapy (SBRT) is a good way to treat tumors near the spinal cord. Patients will either receive a single treatment or 25 days of treatment given once-a-day, Monday through Friday for about 5 continuous weeks. Our protocol uses life expectancy, patient preference, and tumor size to determine whether SBRT is delivered with 1 or 25 treatments. The single treatment dose is 15 Gy. The 25 treatment group is 70 Gy at 2.8 Gy/treatment.

Interventions

  • RADIATION Stereotactic Body Radiation Therapy

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2005-10
Est. Completion 2008-11
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT00631670

The ClinicalTrials.gov registry entry for NCT00631670 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Stereotactic Body Radiation Therapy is the first listed.

NCT00631670 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00631670 about?

NCT00631670 is a clinical study titled "Stereotactic Body Radiation Therapy (SBRT) for Tumors Near the Spinal Cord". The purpose of this research study is to determine if Stereotactic Body Radiation Therapy (SBRT) is a good way to treat tumors near the spinal cord. Patients will either receive a single treatment or 25 days of treatment given once-a-day, Monday through Friday for about 5 continuous weeks. Our proto...

What is the current status of trial NCT00631670?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2005-10. Estimated completion is 2008-11.

What interventions are being tested in trial NCT00631670?

The interventions under investigation include: Stereotactic Body Radiation Therapy (RADIATION).

Who is sponsoring clinical trial NCT00631670?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.